期刊文献+

固本汤联合放射治疗食管癌术后患者疗效观察 被引量:2

Clinical Effect of Guben Decotion Combined with Radiotherapy in Treatment of Patients with Esophageal Carcinoma after Surgery
下载PDF
导出
摘要 目的观察固本汤联合放射治疗对食管癌术后患者疗效的影响。方法选择2002年4月~2006年9月64例食管癌术后患者,随机分为A组(单纯放疗)和B组(固本汤+放疗),观察消化道反应、骨髓抑制、放射性反应和生存期、放疗前后Karnofsky评分,对比两组肿瘤患者的毒副反应和疗效。结果放疗结束按Karnofsky评分,B组明显高于A组,差别显著;B组1、2、3年生存率明显优于A组,差异显著;毒副反应两组对比,消化道反应、骨髓抑制及放射性食管炎(残胃炎)差异有显著性,B组明显低于A组,主要表现为恶心呕吐、白细胞下降,吞咽疼痛及反酸,一般经对症处理均能缓解。结论固本汤联合放射治疗能明显降低毒副反应,提高食管癌术后患者的生存质量,延长生存期。 Objective To observe the effect for the patients with esophageal carcinoma surgery by guben decotion combined with radiotherapy. Methods 64 cases of patients with esophageal carcinoma after surgery were randomly divided into two groups, patients in control group(n = 30) were treated by radiotherapy only. Patients in treatment group( n = 34 ) were treated by guben decotion combined radiotherapy. Investigated the digestive tract response,the marrow suppression,the radioactive response and the lifetime,the Karnofsky grading after the radiotherapy,contrasted two group of tumor patient's poisonous side reaction and the curative effect. Results B group of Karnofsky grading is higher than A group obviously ; B group of lifetimes surpass A group obviously; B group of poisonous side reactions are lower than A group obviously. Conclusion The lifequality and lifetime of the patients with esophageal carcinoma after surgery treated by guben decotion combined with radiotherapy were improved obviously, and the poisonous side reaction of the radiotherapy were reduced obviously.
出处 《中国现代医生》 2009年第17期12-13,共2页 China Modern Doctor
关键词 食管肿瘤 放射疗法 抗肿瘤药(中药) 综合疗法 治疗应用 Esophageal carcinoma Radiotherapy Anti-tumor medicine(Chinese native medicine) Comprehensive therapy Treatment ap-plication
  • 相关文献

参考文献3

二级参考文献11

  • 1董竞成,董晓辉.黄芪注射液与白细胞介素2增强树突细胞抗肿瘤转移作用的比较研究[J].中国中西医结合杂志,2005,25(3):236-239. 被引量:34
  • 2董竞成,刘羽华,宫兆华,董晓辉,谢瑾玉,巫善美,崔焱,蔡蓉,胡燕蓉,倪勤龙,倪世昌.扶正祛邪颗粒对呼吸道病毒感染人群免疫细胞及因子的影响[J].中国中西医结合杂志,2005,25(7):616-619. 被引量:2
  • 3Yamamura M, Modlin RL, Ohmen JD, et al. Local expression of antiinflammatory cytokines in cancer. J Clin Invest, 1993,91:1005-1010.
  • 4Wu PC,Posner MC.The role of surgery in the management of oesophageal cancer[J].Lancet Oncol,2003,4:481 ~ 488.
  • 5Blazeby JM,Alderson D,Winstone K,et al.Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer.The EORTC Quality of Life Study Group[J].Eur J Cancer,1996,32A (11):1912 ~1917.
  • 6Aaronson NK,Ahmedzai S,Bergman B,et al.The European Organization for Research and Treatment of Cancer QLQ-C30:a quality of life instrument for use in international clinical trials in oncology[J].J Natl Cancer Inst,1993,85:365 ~ 376.
  • 7O'Hanlon DM,Harkin M,Karat D,et al.Quality of life assessment in patients undergoing treatment for oesophageal carcinoma[J].Br J Surg,1995,82:1682 ~ 1685.
  • 8Blazeby JM,Farndon JR,Donovan J,et al.A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma[J].Cancer,2000,88(8):1781 ~ 1787.
  • 9Blazeby JM,Brookes ST,Alderson D.The prognostic value of quality of life scores during treatment for oesophageal cancer[J].Gut,2001,49 (2):227 ~ 230.
  • 10孙继萍,肖伟.黄芪对人肺癌细胞株IL-2及IFN-γ的诱生作用[J].山东医药,2000,40(4):9-10. 被引量:14

共引文献53

同被引文献25

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部